Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

15.88 -0.57 (-3.50%)

Streaming Delayed Price Updated: 11:31 AM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

51 52 Next >

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

June 03, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six...

Via StockStory

Topics Stocks

Check Out What Whales Are Doing With HIMS ↗

June 02, 2025

Via Benzinga

Hims & Hers Faces Retail Skepticism After Layoffs, FDA Ban on Compounded Wegovy ↗

June 01, 2025

The company said the layoffs were unrelated to the regulatory change.

Via Stocktwits

Topics Law Enforcement Workforce

3 Health Care Stocks With Whale Alerts In Today's Session ↗

May 30, 2025

Via Benzinga

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly ↗

May 29, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?

Via Investor's Business Daily

Unpacking the Latest Options Trading Trends in Hims & Hers Health ↗

May 28, 2025

Via Benzinga

3 Surprising Stocks That Have More Than Doubled in 2025 ↗

May 27, 2025

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would have predicted.

Via The Motley Fool

Topics Government

Super Micro Computer, Hims & Hers And Aurora Innovation Are Among Top 10 Large-Cap Losers Last Week (May 19-May 23): Are The Others In Your Portfolio? ↗

May 25, 2025

Large-cap stocks were the worst performers last week, with declines up to 23%. Reasons include revenue misses, FDA bans, and Uber's stake monetization.

Via Benzinga

Benzinga Bulls And Bears: Alphabet, L3Harris, Target — And Latest Tariff News Roils Markets ↗

May 24, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

MarketBeat Week in Review – 05/19 - 05/23

May 24, 2025

Stocks were moving lower to end the week as tariff concerns returned; however NVIDIA earnings next week may help investors climb the wall of worry

Via MarketBeat

Topics Artificial Intelligence Bonds Economy

8 Health Care Stocks With Whale Alerts In Today's Session ↗

May 23, 2025

Via Benzinga

Why Hims & Hers Health (HIMS) Stock Is Falling Today

May 22, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications...

Via StockStory

Topics Artificial Intelligence

Hims & Hers Introduces 6-Month Wegovy® New Customer Offer

May 22, 2025

From Hims & Hers

Via Business Wire

Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?

May 22, 2025

The UnitedHealth stock sell-off might have spooked investors in the medical sector, who are wondering if it will affect shares of Hims & Hers equally.

Via MarketBeat

Topics Government World Trade

Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull ↗

May 22, 2025

Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide...

Via Stocktwits

Hims & Hers Health Stock Is Tumbling Thursday: What's Happening? ↗

May 22, 2025

Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 22, 2025

Via Benzinga

Up 157% in 2025, Is It Too Late to Buy Hims & Hers Stock? ↗

May 22, 2025

Via The Motley Fool

Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know

May 21, 2025

A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could...

Via StockStory

Topics Bonds Stocks

Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour ↗

May 21, 2025

The selloff came as investors repriced risk across equities amid fears of persistently higher rates, sparked by soft demand at the 20-year Treasury auction.

Via Benzinga

Unpacking Q1 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks

May 20, 2025

Looking back on healthcare technology stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Hims & Hers Health (NYSE:HIMS) and its peers.

Via StockStory

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 20, 2025

Via Benzinga

Hims & Hers Stock Chart Points to Strong Bullish Continuation

May 20, 2025

Hims & Hers Health, Inc. stock price action shows strongly bullish signs in May and could be ready to hit new highs before the 2nd half starts.

Via MarketBeat

CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? ↗

May 18, 2025

Large-cap stocks surged in the last week. CoreWeave, Super Micro, Coinbase, NRG Energy, Astera Labs, First Solar, Exelixis, Rocket Lab, Hims & Hers, On Holding and Gap were the top performers.

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

May 16, 2025

Via Benzinga

Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month ↗

May 14, 2025

Hims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month.

Via Benzinga

HIMS & HERS HEALTH INC (NYSE:HIMS) – A High-Growth Stock Meeting Minervini’s Trend Template ↗

May 14, 2025

HIMS & HERS HEALTH (NYSE:HIMS) meets Minervini’s Trend Template with strong technicals and explosive earnings growth, making it a high-growth momentum candidate.

Via Chartmill

Hims & Hers Stock Sparks Retail Trader Frenzy After CEO Announces 'Largest Raise Yet' Of $1B ↗

May 13, 2025

CEO Andrew Dudum said it was “more than double what we set out for,” thanks to strong investor demand.

Via Stocktwits

Topics Artificial Intelligence Regulatory Compliance

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 13, 2025

Via Benzinga

Hims & Hers Stock Soars 29% On Strong Q1 Earnings, Subscriber Growth ↗

May 13, 2025

Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report released last week.

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.